These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 16951377)

  • 21. An ocular mucosal administration of nanoparticles containing DNA vaccine pRSC-gD-IL-21 confers protection against mucosal challenge with herpes simplex virus type 1 in mice.
    Hu K; Dou J; Yu F; He X; Yuan X; Wang Y; Liu C; Gu N
    Vaccine; 2011 Feb; 29(7):1455-62. PubMed ID: 21185849
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interleukin-17 enhanced immunoinflammatory lesions in a mouse model of recurrent herpetic keratitis.
    Xia L; Zhang S; Cao Z; Hu Y; Yang H; Wang D
    Microbes Infect; 2013 Feb; 15(2):126-39. PubMed ID: 23159245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of matrix metalloproteinase-9 in angiogenesis caused by ocular infection with herpes simplex virus.
    Lee S; Zheng M; Kim B; Rouse BT
    J Clin Invest; 2002 Oct; 110(8):1105-11. PubMed ID: 12393846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resistance to herpetic stromal keratitis in immunized B-cell-deficient mice.
    Daheshia M; Deshpande S; Chun S; Kuklin NA; Rouse BT
    Virology; 1999 Apr; 257(1):168-76. PubMed ID: 10208930
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Control of stromal keratitis by inhibition of neovascularization.
    Zheng M; Schwarz MA; Lee S; Kumaraguru U; Rouse BT
    Am J Pathol; 2001 Sep; 159(3):1021-9. PubMed ID: 11549594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IL-12 suppresses the expression of ocular immunoinflammatory lesions by effects on angiogenesis.
    Lee S; Zheng M; Deshpande S; Eo SK; Hamilton TA; Rouse BT
    J Leukoc Biol; 2002 Mar; 71(3):469-76. PubMed ID: 11867684
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mice with mutations in Fas and Fas ligand demonstrate increased herpetic stromal keratitis following corneal infection with HSV-1.
    Morris JE; Zobell S; Yin XT; Zakeri H; Summers BC; Leib DA; Stuart PM
    J Immunol; 2012 Jan; 188(2):793-9. PubMed ID: 22156346
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of adjuvant efficacy of herpes simplex virus type 1 recombinant viruses expressing TH1 and TH2 cytokine genes.
    Osorio Y; Ghiasi H
    J Virol; 2003 May; 77(10):5774-83. PubMed ID: 12719570
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recombinant herpes simplex virus type 1 (HSV-1) codelivering interleukin-12p35 as a molecular adjuvant enhances the protective immune response against ocular HSV-1 challenge.
    Osorio Y; Ghiasi H
    J Virol; 2005 Mar; 79(6):3297-308. PubMed ID: 15731224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-metastatic effects of DNA vaccine encoding single-chain trimer composed of MHC I and vascular endothelial growth factor receptor 2 peptide.
    Chen R; Wang S; Yao Y; Zhou Y; Zhang C; Fang J; Zhang D; Zhang L; Pan J
    Oncol Rep; 2015 May; 33(5):2269-76. PubMed ID: 25739076
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Counteracting corneal immunoinflammatory lesion with interleukin-1 receptor antagonist protein.
    Biswas PS; Banerjee K; Zheng M; Rouse BT
    J Leukoc Biol; 2004 Oct; 76(4):868-75. PubMed ID: 15258192
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The enhanced anti-angiogenic and antitumor effects of combining flk1-based DNA vaccine and IP-10.
    Lu XL; Jiang XB; Liu RE; Zhang SM
    Vaccine; 2008 Oct; 26(42):5352-7. PubMed ID: 18723067
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frontline Science: Aspirin-triggered resolvin D1 controls herpes simplex virus-induced corneal immunopathology.
    Rajasagi NK; Bhela S; Varanasi SK; Rouse BT
    J Leukoc Biol; 2017 Nov; 102(5):1159-1171. PubMed ID: 28584076
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Highly Efficacious Herpes Simplex Virus 1 Vaccine Blocks Viral Pathogenesis and Prevents Corneal Immunopathology via Humoral Immunity.
    Royer DJ; Gurung HR; Jinkins JK; Geltz JJ; Wu JL; Halford WP; Carr DJJ
    J Virol; 2016 Jun; 90(11):5514-5529. PubMed ID: 27030264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunization with dendritic cell-based DNA vaccine pRSC-NLDC145.gD-IL21 protects mice against herpes simplex virus keratitis.
    Tang R; Zhai Y; Dong L; Malla T; Hu K
    Immunotherapy; 2018 Mar; 10(3):189-200. PubMed ID: 29370719
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Orally administered DNA vaccine delivery by attenuated Salmonella typhimurium targeting fetal liver kinase 1 inhibits murine Lewis lung carcinoma growth and metastasis.
    Zuo SG; Chen Y; Wu ZP; Liu X; Liu C; Zhou YC; Wu CL; Jin CG; Gu YL; Li J; Chen XQ; Li Y; Wei HP; Li LH; Wang XC
    Biol Pharm Bull; 2010; 33(2):174-82. PubMed ID: 20118536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiangiogenic immunotherapy targeting Flk-1, DNA vaccine and adoptive T cell transfer, inhibits ocular neovascularization.
    Zhang H; Sonoda KH; Hijioka K; Qiao H; Oshima Y; Ishibashi T
    Biochem Biophys Res Commun; 2009 Apr; 381(4):471-476. PubMed ID: 19340941
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of inflammatory cytokine-induced cyclooxygenase 2 in the ocular immunopathologic disease herpetic stromal keratitis.
    Biswas PS; Banerjee K; Kim B; Kinchington PR; Rouse BT
    J Virol; 2005 Aug; 79(16):10589-600. PubMed ID: 16051851
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Application of FGF-2 to modulate herpetic stromal keratitis.
    Kim B; Lee S; Kaistha SD; Rouse BT
    Curr Eye Res; 2006 Dec; 31(12):1021-8. PubMed ID: 17169840
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blocking 4-1BB/4-1BB ligand interactions prevents herpetic stromal keratitis.
    Seo SK; Park HY; Choi JH; Kim WY; Kim YH; Jung HW; Kwon B; Lee HW; Kwon BS
    J Immunol; 2003 Jul; 171(2):576-83. PubMed ID: 12847221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.